Down 30%, Is It Time To Buy This Pharma Giant?
Bristol Myers Squibb (BMY) poses something of a conundrum to investors at the moment. On the one hand, the share price has dramatically underperformed the market, leading to concerns that further declines are on the horizon. And on the other hand, the valuation is starting to look really attractive to bargain hunters.
So, is BMY a buy or a sell? » Read more about: Down 30%, Is It Time To Buy This Pharma Giant? »
Read More3 Dividend Kings for 2023
Are you looking for reliable, long-term investment opportunities? Consider Dividend Kings, the top performers in the stock market known for their consistent dividend payouts. Famous examples include Coca-Cola, Sysco, and Johnson & Johnson. In this post, we’ll examine the track record, current financial health, and future potential of these successful companies.
Coca Cola
Founded in 1886,
» Read more about: 3 Dividend Kings for 2023 »
Read MoreBuffett’s 13-Point Checklist Revealed
Want to rival the performance of the Oracle of Omaha? Here are 13 characteristics that Warren Buffett looks for in a potential investment:
- Strong and consistent financial performance: Buffett looks for companies with a track record of strong financial performance, including strong revenue and earnings growth, as well as a solid balance sheet.
» Read more about: Buffett’s 13-Point Checklist Revealed »
Read MoreCan This Hot Stock Bounce Back After 75% Plunge?
Fiverr Revenue,
» Read more about: Can This Hot Stock Bounce Back After 75% Plunge? »
Read MoreMarket Commentary: 1 Food Stock That Defies All Odds
Famously, it’s been said that the restaurant business is a horrible one. You have to pay the rent, the staff, the food costs, and keep the lights on, and when you’re done with all that you have to hope your menu is right, the chefs show up each day, and the customers like the food.
» Read more about: Market Commentary: 1 Food Stock That Defies All Odds »
Read MoreThe Burst
Market Commentary: 1 Growth Stock That Is Crushing Asia
Crocs (NASDAQ:CROX) has been a roller-coaster of an investment, to say the least. From lows of $10 in 2020 to highs around $180 in 2021 and back under $50 again in 2022, the share price has bucked investors around like a wild bull at a county fair.
And despite falling far short of the market this year –
» Read more about: Market Commentary: 1 Growth Stock That Is Crushing Asia »
Read MoreThe Spotlight
Is This Healthcare Stock The NEXT BIG THING?
Doximity is a cloud-based platform that helps medical professionals connect and collaborate with their colleagues. It has been compared to LinkedIn for doctors by allowing them to search for new job opportunities, keep up with the latest medical research, and communicate with other physicians in a more efficient way.
The company has an estimated 80% of US doctors on the platform in addition to a large number of top pharmaceutical companies and hospitals in the US,
» Read more about: Is This Healthcare Stock The NEXT BIG THING? »
Read MoreThe Daily
Analysts Are Bullish on These Technology Stocks: Advanced Micro Devices (AMD), T Stamp, Inc. Class A (IDAI)
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Advanced Micro Devices (AMD – Research Report) and T Stamp, Inc. Class A (IDAI – Research Report) with bullish sentiments.
Advanced Micro Devices (AMD)
In a report issued on May 16,